nach oben

Community Mental Health Journal

Erschienen in:

01.12.2016 | Original Paper

Profile and Determinants of Disability in Psychotic Disorders in Nigeria

verfasst von: Victor Olufolahan Lasebikan, Olatunde Ayinde

Erschienen in: Community Mental Health Journal | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

We compared profile and predictors of disability among 210 patients with schizophrenia, schizoaffective disorder, bipolar I disorder with psychosis and depression with psychosis, respectively in a Nigerian clinical population, using the WHO Disability Assessment Schedule, (2.0). Severity of psychosis was determined with Positive and Negative Symptoms Scale, functioning was assessed using the Global Assessment of Functioning Scale, medication adherence with the Medication Adherence Questionnaire. Analyses were by SPSS 20.0. There were remarkable differences in the predictors of disability across these psychotic disorders. The findings strengthens the significance of psychosocial rehabilitation in patients with psychosis as clinical remission and medication adherence did not equate functional recovery.

Adegbaju, D. A., Olagunju, A. T., & Uwakwe, R. (2013). A comparative analysis of disability in individuals with bipolar affective disorder and schizophrenia in a sub-Saharan African mental health hospital: Towards evidence-guided rehabilitation intervention. Social Psychiatry and Psychiatric Epidemiology, 6, 6.

Adewuya, A., & Ola, A. (2008). Medication adherence in Nigerian patients with bipolar disorder. Schizophrenia Research, 98, 193–199.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.

Arvilommi, P., Suominen, K., Mantere, O., Valtonen, H., Leppamaki, S., & Isometsa, E. (2015). Predictors of long-term work disability among patients with type I and II bipolar disorder: A prospective 18-month follow-up study. Bipolar Disorders, 17(8), 821–835. doi:10.1111/bdi.12349.CrossRefPubMed

Bachrach, L. L. (2000). Psychosocial rehabilitation and psychiatry in the treatment of schizophrenia—what are the boundaries? Acta Psychiatrica Scandinavica 102(Suppl 407), 6–10.

Bellack, A. S., Green, M. F., Cook, J. A., Fenton, W., Harvey, P. D., Heaton, R. K., Wykes, T. (2007). Assessment of community functioning in people with schizophrenia and other severe mental illnesses: A white paper based on an NIMH-sponsored workshop. Schizophrenia Bulletin, 33(3), 805–822. doi:10.1093/schbul/sbl035.CrossRefPubMed

Canuso, C. M., & Pandina, G. (2007). Gender and schizophrenia. Psychopharmacology Bulletin, 40(4), 178–190.PubMed

Coker, A. O., Lasebikan, V. O., Olugbile, O. B., & Eaton, J. (2011). Psychiatric psychosocial rehabilitation in Nigeria; What needs to be done. Nigerian Journal of Psychiatry, 9(3), 2–9.

Corrigan, P. W., McCracken, S. G., & Holmes, E. P. (2001). Motivational interviews as goal assessment for persons with psychiatric disability. Community Mental Health Journal, 37(2), 113–122.CrossRefPubMed

Cousins, D. A., Butts, K., & Young, A. H. (2009). The role of dopamine in bipolar disorder. Bipolar Disorders, 11(8), 787–806. doi:10.1111/j.1399-5618.2009.00760.x.CrossRefPubMed

Crow, T. J. (1995). A continuum of psychosis, one human gene, and not much else—the case for homogeneity. Schizophrenia Research, 17(2), 135–145.CrossRefPubMed

Dunlop, B. W., & Nemeroff, C. B. (2007). The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry, 64(3), 327–337. doi:10.1001/archpsyc.64.3.327.CrossRefPubMed

Endicott, J., Spitzer, R. L., Fleiss, J. L., & Cohen, J. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33(6), 766–771.CrossRefPubMed

First, M., Spitzer, R., Gibbon, M., & Williams, J. (1996). Structured clinical interview for DSM-IV axis I disorders, clinical version (SCID-CV).. Washington, DC: American Psychiatric Press, Inc.

Gade, K., Malzahn, D., Anderson-Schmidt, H., Strohmaier, J., Meier, S., Frank, J., Schulze, & T, G. (2015). Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: A potential cross-diagnostic phenotype for further genetic investigations? The World Journal Of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry, 16(4), 237–248. doi:10.3109/15622975.2014.995221.CrossRef

Green, M. F. (2006). Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry, 67(Suppl 9), 3–8 (discussion 36–42)PubMed

Gureje, O. (2007). Psychiatry in Africa: The myths, the exotic, and the realities. South African Journal of Psychiatry, 10, 11–14.

Gureje, O., Abdulmalik, J., Kola, L., Musa, E., Yasamy, M. T., & Adebayo, K. (2015). Integrating mental health into primary care in Nigeria: Report of a demonstration project using the mental health gap action programme intervention guide. BMC Health Services Research, 15, 242. doi:10.1186/s12913-015-0911-3.CrossRefPubMedPubMedCentral

Gureje, O., & Bamidele, R. (1999). Thirteen-year social outcome among Nigerian outpatients with schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 34(3), 147–151.CrossRefPubMed

Gureje, O., Herrman, H., Harvey, C., Morgan, V., & Jablensky, A. (2002). The Australian National Survey of Psychotic Disorders: Profile of psychosocial disability and its risk factors. Psychological Medicine, 32(4), 639–647.CrossRefPubMed

Gureje, O., & Lasebikan, V. (2006). Use of mental health services in a developing country. Results from the Nigerian survey of mental health and well-being. Social Psychiatry and Psychiatric Epidemiology, 41(1), 44–49.CrossRefPubMed

Gureje, O., Lasebikan, V. O., Ephraim-Oluwanuga, O., Olley, B. O., & Kola, L. (2005). Community study of knowledge of and attitude to mental illness in Nigeria. The British Journal of Psychiatry, 186(5), 436–441. doi:10.1192/bjp.186.5.436.CrossRefPubMed

Hirschfeld, R. M., Calabrese, J. R., Frye, M. A., Lavori, P. W., Sachs, G., Thase, M. E., & Wagner, K. D. (2007). Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. Psychopharmacology Bulletin, 40(3), 7–14.PubMed

Holma, I. A., Holma, K. M., Melartin, T. K., Rytsala, H. J., & Isometsa, E. T. (2012). A 5-year prospective study of predictors for disability pension among patients with major depressive disorder. Acta Psychiatrica Scandinavica, 125(4), 325–334. doi:10.1111/j.1600-0447.2011.01785.x.CrossRefPubMed

Institute of Medicine Committee on Nervous System Disorders in Developing, C. (2001) Neurological, Psychiatric, and Developmental Disorders: Meeting the Challenge in the Developing World. Washington (DC): National Academies Press (US), Copyright 2001 by the National Academy of Sciences. All rights reserved.

Kane, J. M., Carson, W. H., Saha, A. R., McQuade, R. D., Ingenito, G. G., Zimbroff, D. L., & Ali, M. W. (2002). Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. The Journal of Clinical Psychiatry, 63(9), 763–771.CrossRefPubMed

Kigozi, F., & Kinyanda, E. (2006). Psychiatric rehabilitation today:An African perspective. World Psychiatry, 5(3), 166–166.PubMedPubMedCentral

Lasebikan, V. O. (2016). Cultural aspects of mental health and mental health service delivery with a focus on Nigeria within a global community. Mental Health Religion Culture. doi:10.1080/13674676.2016.1180672.

Lasebikan, V. O., Owoaje, E. T., & Asuzu, M. C. (2012). Social network as a determinant of pathway to mental health service utilization among psychotic patients in a Nigerian hospital. Annals of African Medicine, 11(1), 12–20. doi:10.4103/1596-3519.91010.CrossRefPubMed

Lay, B., Blanz, B., Hartmann, M., & Schmidt, M. H. (2000). The psychosocial outcome of adolescent-onset schizophrenia: A 12-year followup. Schizophrenia Bulletin, 26(4), 801–816.CrossRefPubMed

Lee, R. S., Hermens, D. F., Naismith, S. L., Lagopoulos, J., Jones, A., Scott, J., … Hickie (2015). Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: A longitudinal cohort study. Translational Psychiatry, 5, e555. doi:10.1038/tp.2015.50.CrossRefPubMedPubMedCentral

Leighton, A. H., Lambo, T. A., Hughes, C. C., et al. (1963). Psychiatric disorder among the Yoruba. Ithaca: Cornell University Press.

Leucht, S., Arbter, D., Engel, R. R., Kissling, W., & Davis, J. M. (2009). How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials. Molecular Psychiatry, 14(4), 429–447. doi:10.1038/sj.mp.4002136.CrossRefPubMed

Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006). Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet, 367(9524), 1747–1757. doi:10.1016/s0140-6736(06)68770-9.CrossRefPubMed

Maier, W., Lichtermann, D., Minges, J., Hallmayer, J., Heun, R., Benkert, O., & Levinson, D. F. (1993). Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study. Archives of General Psychiatry, 50(11), 871–883.CrossRefPubMed

Misdrahi, D., Petit, M., Blanc, O., Bayle, F., & Llorca, P. M. (2012). The influence of therapeutic alliance and insight on medication adherence in schizophrenia. Nordic Journal of Psychiatry, 66(1), 49–54. doi:10.3109/08039488.2011.598556.CrossRefPubMed

Mittendorfer-Rutz, E., Härkänen, T., Tiihonen, J., & Haukka, J. (2014). Association of Socio-Demographic Factors, Sick-Leave and Health Care Patterns with the Risk of Being Granted a Disability Pension among Psychiatric Outpatients with Depression. PLoS One, 9(6), e99869. doi:10.1371/journal.pone.0099869.CrossRefPubMedPubMedCentral

Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74.CrossRefPubMed

Murray, C. J., & Lopez, A. D. (1997). Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet, 349(9064), 1498–1504. doi:10.1016/s0140-6736(96)07492-2.CrossRefPubMed

Murray, R. M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research, 71(2–3), 405–416. doi:10.1016/j.schres.2004.03.002.CrossRefPubMed

Nguyen, D., & Bornheimer, L. A. (2014). Mental health service use types among Asian Americans with a psychiatric disorder: Considerations of culture and need. The Journal of Behavioral Health Services & Research, 41(4), 520–528. doi:10.1007/s11414-013-9383-6.CrossRef

Nil, R., Lutolf, S., & Seifritz, E. (2016). Residual symptoms and functionality in depressed outpatients: A one-year observational study in Switzerland with escitalopram. Journal of Affective Disorders, 197, 245–250. doi:10.1016/j.jad.2016.02.062.CrossRefPubMed

Novick, D., Montgomery, W., Treuer, T., Aguado, J., Kraemer, S., & Haro, J. M. (2015). Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: Results from a 1-year European outpatient observational study. BMC Psychiatry, 15, 189. doi:10.1186/s12888-015-0560-4.CrossRefPubMedPubMedCentral

Olsson, A. K., Hjarthag, F., & Helldin, L. (2016). Predicting real-world functional milestones in schizophrenia. Psychiatry Research, 242, 1–6. doi:10.1016/j.psychres.2016.05.015.CrossRefPubMed

Piccinelli, M., & Wilkinson, G. (2000). Gender differences in depression. Critical review. The British Journal of Psychiatry: The Journal of Mental Science, 177, 486–492.CrossRef

Pinna, F., Deriu, L., Lepori, T., Maccioni, R., Milia, P., Sarritzu, E., … Carpiniello, B. (2013). Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders. Psychiatry Research, 210(3), 739–744. doi:10.1016/j.psychres.2013.08.022.CrossRefPubMed

RÖSsler, W. (2006). Psychiatric rehabilitation today: An overview. World Psychiatry, 5(3), 151–157.PubMedPubMedCentral

Rytsala, H. J., Melartin, T. K., Leskela, U. S., Sokero, T. P., Lestela-Mielonen, P. S., & Isometsa, E. T. (2007). Predictors of long-term work disability in Major Depressive Disorder: A prospective study. Acta Psychiatrica Scandinavica, 115(3), 206–213. doi:10.1111/j.1600-0447.2006.00878.x.CrossRefPubMed

Schoeyen, H. K., Vaaler, A. E., Auestad, B. H., Malt, U. F., Melle, I., Andreassen, O. A., & Morken, G. (2011). Despite clinical differences, bipolar disorder patients from acute wards and outpatient clinics have similar educational and disability levels compared to the general population. Journal of Affective Disorders, 132(1–2), 209–215. doi:10.1016/j.jad.2011.02.025.CrossRefPubMed

Singh, M. M., & Kay, S. R. (1975). A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics. Psychopharmacologia, 43(2), 103–113.CrossRefPubMed

Starling, J., Williams, L. M., Hainsworth, C., & Harris, A. W. (2013). The presentation of early-onset psychotic disorders. The Australian and New Zealand Journal of Psychiatry, 47(1), 43–50. doi:10.1177/0004867412463615.CrossRefPubMed

Stentebjerg-Olesen, M., Pagsberg, A. K., Fink-Jensen, A., Correll, C. U., & Jeppesen, P. (2016). Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. doi:10.1089/cap.2015.0097.PubMed

Szoke, A., Meary, A., Trandafir, A., Bellivier, F., Roy, I., Schurhoff, F., & Leboyer, M. (2008). Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder. European Psychiatry: The Journal of the Association of European Psychiatrists, 23(1), 20–25. doi:10.1016/j.eurpsy.2007.10.006.CrossRef

Tohen, M., Goldberg, J. F., Gonzalez-Pinto Arrillaga, A. M., Azorin, J. M., Vieta, E., Hardy-Bayle, M. C., … Breier, A (2003). A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Archives of General Psychiatry, 60(12), 1218–1226. doi:10.1001/archpsyc.60.12.1218.CrossRefPubMed

World Health Organization. (1994). The ICD-10 Classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines (10th ed.). Geneva: World Health Organization.

Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Boerescu, D., & Attiullah, N. (2006). Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: Implications for how remission from depression should be defined. Psychiatry Research, 141(2), 185–191. doi:10.1016/j.psychres.2005.05.016.CrossRefPubMed

Titel: Profile and Determinants of Disability in Psychotic Disorders in Nigeria
verfasst von: Victor Olufolahan Lasebikan
Olatunde Ayinde
Publikationsdatum: 01.12.2016
Verlag: Springer US
Erschienen in: Community Mental Health Journal / Ausgabe 8/2017
Print ISSN: 0010-3853
Elektronische ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-016-0070-y

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Profile and Determinants of Disability in Psychotic Disorders in Nigeria

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Navigating the Disability Determination Process from the Perspective of Incarcerated Adults with Serious Mental Illnesses

Editor’s Comments

Clinical Factors Associated with Successful Discharge from Assertive Community Treatment

The Impact of Criminal Justice Involvement and Housing Outcomes Among Homeless Persons with Co-occurring Disorders

Explanatory Models of Illness, Help Seeking Behaviours and Related Factors in Patients with Schizophrenia: A Comparative Study from Two Different Provinces of Turkey

Understanding Etiology of Hearing Loss as a Contributor to Language Dysfluency and its Impact on Assessment and Treatment of People who are Deaf in Mental Health Settings

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie